|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 36 of 62 found articles
| Title: |
43P MRTX-500: Phase II trial of sitravatinib (sitra) + nivolumab (nivo) in patients (pts) with non-squamous (NSQ) non-small cell lung cancer (NSCLC) progressing on or after prior checkpoint inhibitor (CPI) therapy |
| Author: |
Leal, T.A. Berz, D. Rybkin, I. Iams, W.T. Bruno, D. Blakely, C. Spira, A. Patel, M. Waterhouse, D.M. Richards, D. Pham, A. Jotte, R. Garon, E.B. Hong, D.S. Shazer, R. Yan, X. Latven, L. He, K. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S1 pages S19-S20 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 36 of 62 found articles
| << previous | next >> |